AU2003300499A1 - Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases - Google Patents

Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases

Info

Publication number
AU2003300499A1
AU2003300499A1 AU2003300499A AU2003300499A AU2003300499A1 AU 2003300499 A1 AU2003300499 A1 AU 2003300499A1 AU 2003300499 A AU2003300499 A AU 2003300499A AU 2003300499 A AU2003300499 A AU 2003300499A AU 2003300499 A1 AU2003300499 A1 AU 2003300499A1
Authority
AU
Australia
Prior art keywords
carrying
curing skin
porphyrin synthesis
out phototherapy
synthesis substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300499A
Other languages
English (en)
Inventor
Gerhard Saalmann
Peter Saalmann
Hagen Tronnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003300499A1 publication Critical patent/AU2003300499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003300499A 2003-01-17 2003-12-23 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases Abandoned AU2003300499A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10301917A DE10301917B4 (de) 2003-01-17 2003-01-17 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
DE10301917.0 2003-01-17
PCT/DE2003/004254 WO2004064827A1 (de) 2003-01-17 2003-12-23 Verwendung von substanzen der porphyrinsynthese für die anwendung in der phototherapie sowie zur behandlung von haut- und/oder gelenkerkrankungen

Publications (1)

Publication Number Publication Date
AU2003300499A1 true AU2003300499A1 (en) 2004-08-13

Family

ID=32602752

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300499A Abandoned AU2003300499A1 (en) 2003-01-17 2003-12-23 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases

Country Status (13)

Country Link
US (1) US20070099878A1 (enExample)
EP (1) EP1583525B1 (enExample)
JP (1) JP2006514072A (enExample)
AT (1) ATE479431T1 (enExample)
AU (1) AU2003300499A1 (enExample)
CY (1) CY1110957T1 (enExample)
DE (2) DE10301917B4 (enExample)
DK (1) DK1583525T3 (enExample)
ES (1) ES2351971T3 (enExample)
PT (1) PT1583525E (enExample)
RU (1) RU2336078C2 (enExample)
SI (1) SI1583525T1 (enExample)
WO (1) WO2004064827A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
DE102011117364A1 (de) * 2011-10-29 2013-05-02 Merck Patent Gmbh Hautaufheller in der Phototherapie
DE202013003573U1 (de) 2013-04-16 2013-06-04 Gerhard Saalmann Ganzkörper-Belichtungseinheit
RU2712806C1 (ru) * 2019-05-20 2020-01-31 Федеральное государственное бюджетное учреждение "Государственный научный центр лазерной медицины имени О.К. Скобелкина Федерального медико-биологического агентства" Способ лечения больных перипротезной инфекцией после эндопротезирования сустава

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
DE4440112A1 (de) * 1994-11-11 1996-05-15 Jan H Dr Wilkens Bestrahlungsanordnung zur Behandlung von Hauterkrankungen
US5530157A (en) * 1995-02-16 1996-06-25 Scios Nova Inc. Anti-inflammatory benzoic acid derivatives
CZ291132B6 (cs) * 1995-03-10 2002-12-11 Photocure Asa Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem
US5942534A (en) * 1996-10-10 1999-08-24 The General Hospital Corporation Photodynamic therapy for the treatment of osteoarthritis
RU2145247C1 (ru) * 1998-04-10 2000-02-10 Жаров Владимир Павлович Фотоматричное терапевтическое устройство для лечения протяженных патологий
WO2000002491A1 (en) * 1998-07-09 2000-01-20 Curelight Ltd. Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
ES2243549T3 (es) * 2000-09-08 2005-12-01 Vivier Canada Inc. Soluciones de acido ascorbico estabilizadas.
DE10063076A1 (de) * 2000-12-18 2002-06-27 Medac Klinische Spezialpraep Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe
US20030082101A1 (en) * 2001-06-11 2003-05-01 Cavalier Discovery Accelerators for increasing the rate of formation of free radicals and reactive oxygen species
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders

Also Published As

Publication number Publication date
DE10301917B4 (de) 2007-02-01
DE10301917A1 (de) 2004-07-29
ES2351971T3 (es) 2011-02-14
RU2005127035A (ru) 2006-01-27
DE50313052D1 (de) 2010-10-14
SI1583525T1 (sl) 2011-01-31
DK1583525T3 (da) 2011-01-03
EP1583525A1 (de) 2005-10-12
ATE479431T1 (de) 2010-09-15
JP2006514072A (ja) 2006-04-27
PT1583525E (pt) 2010-12-07
RU2336078C2 (ru) 2008-10-20
EP1583525B1 (de) 2010-09-01
WO2004064827A1 (de) 2004-08-05
US20070099878A1 (en) 2007-05-03
CY1110957T1 (el) 2015-06-11

Similar Documents

Publication Publication Date Title
AU2003248747A1 (en) Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
IL189019A0 (en) Pdt (photodynamic therapy) treatment method for cellulites and cosmetic use
GB2444855B8 (en) Apparatus and method for photodynamic diagnosis and therapy of skin diseases and light source systemthereof
WO2005030317A3 (en) Phototherapeutic treatment of skin conditions
PL2471512T3 (pl) Formulacje niepolarnych fotouczulaczy do terapii fotodynamicznej
AU2004207813A8 (en) Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles
WO2002096366A3 (en) Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
AU2003903387A0 (en) Combination therapy for treatment of neoplasia
WO2004080284A3 (en) Antibody-targeted photodynamic therapy
WO2003028629A3 (en) Chlorin photosensitizing agents for use in photodynamic therapy
WO2003004466A3 (en) Dye-sulfenates for dual phototherapy
KR101663346B1 (ko) 안면유도장치 및 안면유도방법
AU2003300499A1 (en) Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
WO2003003806A3 (en) Dye-azide compounds for dual phototherapy
AU2003209150A1 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
MXPA04007443A (es) Nuevos compuestos de porfirina-platino solubles en agua con alta selectividad tumoral y su uso para el tratamiento de enfermedades tumorales benignas y malignas.
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2002364501A1 (en) Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
AU2003220338A1 (en) Photosensitizers for photodynamic therapy of microbial infections
EP4251080A4 (en) NON-INVASIVE TREATMENT OF CANCER WITH MULTI-WAVELENGTH LASER
AU2003297570A1 (en) Treatment of skin diseases
AU2003219902A1 (en) Photodynamic diagnosis of oral cancer
AU2002346661A1 (en) Photodynamic therapy for the treatment of epilepsy
AU2003260162A1 (en) Hand-held light applicator for medical therapeutic irradiation in small corporeal orifices and interstices
HK1072561A (en) Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase